Form 8-K · Current report

Amgen 8-K, filed Jul 31, 2026

Filed
CIK
0000318154
Accession no.
0000318154-26-000119
AI-generated summary

Summary

Amgen determined that a July 2026 cybersecurity incident involving unauthorized activity in third-party cloud environments is material, after proprietary data and patient protected health information were exfiltrated. Amgen said it has not identified impact to its products, manufacturing operations, financial reporting systems, or ability to meet patient needs, and believes the incident is not reasonably likely to materially affect its financial condition or results of operations.

Key points

  • Amgen identified unauthorized activity in cloud environments hosted by third-party providers in July 2026, activated its cybersecurity response plan, implemented containment measures, and engaged independent forensic experts.
  • Some Amgen data, including proprietary data and patient protected health information, was exfiltrated from those cloud environments.
  • On July 29, 2026, Amgen determined the incident is material based on the volume of files apparently impacted and the potential sensitivity of the information.
  • The investigation is ongoing, and Amgen is evaluating regulatory and legal notification requirements, including notifications to impacted patients.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

Items reported

  • 1.05Material Cybersecurity Incidents

From the filing

Item 1.05 Material Cybersecurity Incidents. In July 2026, Amgen Inc. (the "Company") identified unauthorized activity involving data stored in cloud environments hosted by third-party cloud service providers. Upon detecting the activity, the Company activated its cybersecurity response plan, implemented containment measures, and engaged independent cybersecurity forensic experts. The Company has since learned that some of its data, including proprietary data, patient protected health information, and other information, has been exfiltrated from these cloud environments. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Amgen in Readster

Add Amgen to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.